MIT Technology Review September 11, 2020
Will Heaven
The guidelines ensure that medical AI research is subject to the same scrutiny as drug development and diagnostic tests.
The news: An international consortium of medical experts has introduced the first official standards for clinical trials that involve
artificial intelligence. The move comes at a time when hype around medical AI is at a peak, with inflated and unverified claims about the effectiveness of certain tools threatening to undermine people’s trust in AI overall.
What it means: Announced in Nature Medicine, the British Medical Journal, and the Lancet, the new standards extend two sets of guidelines around how clinical trials are conducted and reported that are already used around the world for drug development, diagnostic tests,...
Related Articles: